Literature DB >> 22523250

A model of preeclampsia in rats: the reduced uterine perfusion pressure (RUPP) model.

Jing Li1, Babbette LaMarca, Jane F Reckelhoff.   

Abstract

Preeclampsia is defined as new-onset hypertension with proteinuria after 20 wk gestation and is hypothesized to be due to shallow trophoblast invasion in the spiral arteries thus resulting in progressive placental ischemia as the fetus grows. Many animal models have been developed that mimic changes in maternal circulation or immune function associated with preeclampsia. The model of reduced uterine perfusion pressure in pregnant rats closely mimics the hypertension, immune system abnormalities, systemic and renal vasoconstriction, and oxidative stress in the mother, and intrauterine growth restriction found in the offspring. The model has been successfully used in many species; however, rat and primate are the most consistent in comparison of characteristics with human preeclampsia. The model suffers, however, from lack of the ability to study the mechanisms responsible for abnormal placentation that ultimately leads to placental ischemia. Despite this limitation, the model is excellent for studying the consequences of reduced uterine blood flow as it mimics many of the salient features of preeclampsia during the last weeks of gestation in humans. This review discusses these features.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22523250      PMCID: PMC3404644          DOI: 10.1152/ajpheart.00117.2012

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  103 in total

Review 1.  Immunology of pre-eclampsia.

Authors:  Christopher W G Redman; Ian L Sargent
Journal:  Am J Reprod Immunol       Date:  2010-03-23       Impact factor: 3.886

2.  Adenoviral delivery of VEGF121 early in pregnancy prevents spontaneous development of preeclampsia in BPH/5 mice.

Authors:  Ashley K Woods; Darren S Hoffmann; Christine J Weydert; Scott D Butler; Yi Zhou; Ram V Sharma; Robin L Davisson
Journal:  Hypertension       Date:  2010-11-15       Impact factor: 10.190

3.  Production of experimental toxemia in the pregnant dog.

Authors:  M M Abitbol; C L Pirani; W B Ober; S G Driscoll; M W Cohen
Journal:  Obstet Gynecol       Date:  1976-11       Impact factor: 7.661

4.  Contribution of PARP to endothelial dysfunction and hypertension in a rat model of pre-eclampsia.

Authors:  S K Walsh; F A English; I P Crocker; E J Johns; L C Kenny
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

5.  Autoantibodies to the angiotensin type I receptor in response to placental ischemia and tumor necrosis factor alpha in pregnant rats.

Authors:  Babbette LaMarca; Gerd Wallukat; Mayte Llinas; Florian Herse; Ralf Dechend; Joey P Granger
Journal:  Hypertension       Date:  2008-10-13       Impact factor: 10.190

6.  Role of reactive oxygen species in hypertension produced by reduced uterine perfusion in pregnant rats.

Authors:  Mona Sedeek; Jeffrey S Gilbert; Babbette B LaMarca; Myssara Sholook; Derrick L Chandler; Yuping Wang; Joey P Granger
Journal:  Am J Hypertens       Date:  2008-07-31       Impact factor: 2.689

7.  Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1.

Authors:  Babbette LaMarca; Marc Parrish; Lillian Fournier Ray; Sydney R Murphy; Lyndsay Roberts; Porter Glover; Gerd Wallukat; Katrin Wenzel; Kathy Cockrell; James N Martin; Michael J Ryan; Ralf Dechend
Journal:  Hypertension       Date:  2009-08-24       Impact factor: 10.190

8.  Hypertension in response to IL-6 during pregnancy: role of AT1-receptor activation.

Authors:  Babbette Lamarca; Joshua Speed; Lillian Fournier Ray; Kathy Cockrell; Gerd Wallukat; Ralf Dechend; Joey Granger
Journal:  Int J Interferon Cytokine Mediat Res       Date:  2011-11

9.  Systemic hemodynamic and regional blood flow changes in response to chronic reductions in uterine perfusion pressure in pregnant rats.

Authors:  M M Sholook; J S Gilbert; M H Sedeek; M Huang; R L Hester; J P Granger
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-07-20       Impact factor: 4.733

Review 10.  Pre-eclampsia: pathophysiology, diagnosis, and management.

Authors:  Jennifer Uzan; Marie Carbonnel; Olivier Piconne; Roland Asmar; Jean-Marc Ayoubi
Journal:  Vasc Health Risk Manag       Date:  2011-07-19
View more
  78 in total

Review 1.  Sex, Oxidative Stress, and Hypertension: Insights From Animal Models.

Authors:  Jane F Reckelhoff; Damian G Romero; Licy L Yanes Cardozo
Journal:  Physiology (Bethesda)       Date:  2019-05-01

2.  Interleukin-17 signaling mediates cytolytic natural killer cell activation in response to placental ischemia.

Authors:  Olivia K Travis; Dakota White; Cedar Baik; Chelsea Giachelli; Willie Thompson; Cassandra Stubbs; Mallory Greer; James P Lemon; Jan Michael Williams; Denise C Cornelius
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2020-04-22       Impact factor: 3.619

3.  Effect of nicotine on placental ischemia-induced complement activation and hypertension in the rat.

Authors:  Connor F Laule; Cameron R Wing; Evan J Odean; Jacob A Wilcox; Jeffrey S Gilbert; Jean F Regal
Journal:  J Immunotoxicol       Date:  2017-12       Impact factor: 3.000

4.  IL-10 supplementation increases Tregs and decreases hypertension in the RUPP rat model of preeclampsia.

Authors:  Ashlyn Harmon; Denise Cornelius; Lorena Amaral; Adrienne Paige; Florian Herse; Tarek Ibrahim; Gerd Wallukat; Jessica Faulkner; Janae Moseley; Ralf Dechend; Babbette LaMarca
Journal:  Hypertens Pregnancy       Date:  2015-05-21       Impact factor: 2.108

5.  An increased population of regulatory T cells improves the pathophysiology of placental ischemia in a rat model of preeclampsia.

Authors:  Denise C Cornelius; Lorena M Amaral; Ashlyn Harmon; Kedra Wallace; Alexia J Thomas; Nathan Campbell; Jeremy Scott; Florian Herse; Nadine Haase; Janae Moseley; Gerd Wallukat; Ralf Dechend; Babbette LaMarca
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-08-19       Impact factor: 3.619

Review 6.  The heme oxygenases: important regulators of pregnancy and preeclampsia.

Authors:  Eric M George; Junie P Warrington; Frank T Spradley; Ana C Palei; Joey P Granger
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-06-04       Impact factor: 3.619

7.  Heme oxygenase-1 is a potent inhibitor of placental ischemia-mediated endothelin-1 production in cultured human glomerular endothelial cells.

Authors:  Bhavisha A Bakrania; Frank T Spradley; Simon C Satchell; David E Stec; John M Rimoldi; Rama S V Gadepalli; Joey P Granger
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-12-06       Impact factor: 3.619

8.  AT1-AA (Angiotensin II Type 1 Receptor Agonistic Autoantibody) Blockade Prevents Preeclamptic Symptoms in Placental Ischemic Rats.

Authors:  Mark W Cunningham; Javier Castillo; Tarek Ibrahim; Denise C Cornelius; Nathan Campbell; Lorena Amaral; Venkata Ramana Vaka; Nathan Usry; Jan M Williams; Babbette LaMarca
Journal:  Hypertension       Date:  2018-03-19       Impact factor: 10.190

9.  Demystifying animal models of adverse pregnancy outcomes: touching bench and bedside.

Authors:  Elizabeth A Bonney
Journal:  Am J Reprod Immunol       Date:  2013-02-28       Impact factor: 3.886

10.  Elevated vasopressin in pregnant mice induces T-helper subset alterations consistent with human preeclampsia.

Authors:  Sabrina M Scroggins; Donna A Santillan; Jenna M Lund; Jeremy A Sandgren; Lindsay K Krotz; Wendy S Hamilton; Eric J Devor; Heather A Davis; Gary L Pierce; Katherine N Gibson-Corley; Curt D Sigmund; Justin L Grobe; Mark K Santillan
Journal:  Clin Sci (Lond)       Date:  2018-02-14       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.